Pharma giants from Johnson & Johnson to Novartis to Roche, looking for edges in speed and convenience, have unveiled self-injection options to replace intravenous infusions in the fields of cancer, ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may recommend a biologic, a type of drug that targets the part of the immune system responsible for ...

ALBANY, N.Y., April 1, 2021 /PRNewswire/ -- Self-injection devices have become a mainstay of numerous infusion therapies for long-term management of chronic conditions, mainly by making subcutaneous ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...